Disease
|
Drug/Important Bio-Agent (IBA)
18 | Temozolomide (Temodar)FDA LinkGeneric
01/2022
-
12/2003 |
17 | Bevacizumab (Avastin)FDA Link
01/2022
-
11/2012 |
3 | MethyltransferasesIBA
01/2019
-
04/2007 |
2 | SteamIBA
04/2024
-
12/2023 |
2 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
04/2024
-
12/2023 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020
-
11/2012 |
2 | Biomarkers (Surrogate Marker)IBA
01/2018
-
01/2017 |
2 | Monoclonal AntibodiesIBA
07/2015
-
11/2012 |
1 | Proteins (Proteins, Gene)FDA Link
12/2023 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2023 |
1 | Alkylating AgentsIBA
12/2023 |
1 | Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022 |
1 | Angiogenesis InhibitorsIBA
01/2022 |
1 | ChromatinIBA
01/2019 |
1 | O-(6)-methylguanineIBA
01/2019 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2019 |
1 | AnticoagulantsIBA
01/2018 |
1 | vasectrin IIIIBA
01/2018 |
1 | onartuzumabIBA
01/2017 |
1 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2017 |
1 | LigandsIBA
01/2017 |
1 | TB-403IBA
07/2015 |
1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2015 |
1 | CilengitideIBA
09/2014 |
1 | Adrenal Cortex Hormones (Corticosteroids)IBA
05/2013 |
|
Therapy/Procedure
|